This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $118,026.03 firm fixed price delivery order provides Illumina's NovaSeq 6000 sequencing reagents, Illumina DNA PCR-free sample preparation kits, and other sequencing consumables to support the agency's research and...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing systems. The $247,444.82 award does not have a set-aside designation. Illumina has been a prime contractor on prior federal awards...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, with a potential value of $247,511.00. The order includes TruSeq Stranded Total RNA Library Prep Gold kits, NovaSeq 6000 reagent kits, and other sequencing consumables. This award is not associated with a larger contract vehicle and...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a firm fixed price delivery order contract worth $64,960.00 to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The contract is for the provision of 01-NOVASEQ X SERIES 25B REAGENT KIT (300 CYC) with a completion date of September 2, 2025. Illumina has previously received prime federal contracts from...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $206,147.52 firm fixed price delivery order contract to Illumina, Inc. for sequencing reagent kits to support the agency's Illumina NovaSeq X Plus sequencer. As the sole manufacturer of the sequencer, Illumina will provide proprietary consumables and reagents to enable genomic sequencing activities at the specified San Diego, California...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $174,225.46 firm fixed price delivery order to Illumina, Inc. for the purchase of sequencing reagent kits to support the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencers. This award was not set aside. Illumina is a manufacturer of genomic sequencing and analytical instruments, and has provided a range of...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 2000 sequencers. The $202,227.89 award has a completion date of September 2, 2025 and does not utilize any set-aside designations....
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a firm-fixed-price delivery order contract worth $247,444.82 to Illumina, Inc. to purchase sequencing reagent kits for the agency's Illumina NovaSeq 6000 and NextSeq 550 sequencing instruments. The contract has a completion date of September 2, 2025. Illumina is a manufacturer of genetic and genomic analysis instruments and...
The Department of Health and Human Services National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a $75,014.08 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract calls for Illumina to provide sequencing reagent kits for the agency's Illumina NovaSeq X Plus, NovaSeq 6000, and NextSeq 2000 sequencers to support its research efforts. No subcontractors or set aside designations were indicated. This...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, awarded a $999,999.00 firm fixed price purchase order to Illumina, Inc. to provide a NovaSeq X Plus sequencing system. This award is based on a September 2023 solicitation from the National Heart Lung and Blood Institute seeking a high-throughput DNA sequencing platform to support genomic research. The contract has no set-aside designation and a...